Sentences with phrase «drug companies do»

Too often, drug companies do not sufficiently test their products before making them available to the public.

This moves the process along and the drug companies do have motivation to abide.

Art doesn't purport to have all the answers; the drug companies do... I believe painting and all art should be ultimately uplifting for a viewer.

Art doesn't purport to have all the answers; the drug companies do.

Many drug companies do not guarantee their product unless purchased through a veterinarian which is why pet owners need to be cautious when purchasing medications for their pets online.

Marc dispels many «bodybuilding myths», tells you what most people never realize about nutrition, and what the drug companies DO N'T WANT YOU to know.

Plus, I'll let you in on a secret that the drug companies don't want you to know about.

Statin Free - How to maintain a healthy heart without statin drugs, using simple techniques the drug companies don't want you to know about

And, naturally, the drug companies don't want you to know that part of the science because it would severely limit the number of people going on cholesterol - lowering drugs, since statins do not modulate the size of the particles.

Colloidal Silver: What the Drug Companies Don't Want You To Know — This is the original 60 - minute audio - taped interview on CD, featuring Dr. Gary North interviewing Steve Barwick, author of The Ultimate Colloidal Silver Manual!

That cash doesn't include the money PhRMA's spending on the ongoing «Go Boldly» campaign, a series of TV, print and radio ads designed to polish the drug industry's image by reminding the public that drug companies do world - class research that brings disease cures to market to save lives.

But one drug company did provide useful information, right?

A: Yes, the FDA approved two medications for RLS, one right after the other, and the drug companies did an aggressive disease awareness program with ads on television.

In their Lipitor lawsuits, the plaintiffs contend that the drug company did not warn that the statin medication could up the risk of Type 2 A diabetes.

The drug company doesn't specify where the cuts will be made but, based on past performance, it's reasonable to assume that Hospira employees may be feeling a little unsure in the coming year.

Not exact matches

Never mind that the company doesn't even have a single drug of its own in clinical trials.

The companies do have competing drugs.

It doesn't make the drugs itself; it leases medicines from companies, conducts phase 1 and 2 testing, and then it leases the drug to a larger business to conduct phase 3 testing.

These rebates, struck between drug makers, pharmacy benefits managers, insurance companies, employers, and others, are largely negotiated in the background; but they don't necessarily trickle down to patients and consumers themselves.

The company has responded with statements saying that it's not as dependent on drug price increases as critics have claimed; it has also pointed out that while attention has focused on changes in list prices for drugs, those prices don't reflect the actual cost for insurers, governments and other group purchasers, which typically receive discounts that aren't publicly disclosed.

Meanwhile, despite much talk about change, Congress and the Trump administration have done little to control drug prices or threaten drug - company profits.

While several of the present CEOs responded optimistically to the meeting — praising the deregulation and tax reduction components in particular — and many of their companies» shares rose on hopes that Trump won't be as antagonistic toward drug makers as his recent comments that they're «getting away with murder» on prices would suggest, don't count on the wish list to come true.

Indeed, it didn't have anything do with a drug or insurance company at all.

The lawyers come, as do the sales reps.. As the company fights to get approval for its first marketable drug, Incivek, an oral treatment for Hepatitis C, there is an outbreak of practicality at the company.

Even after the outrage the drug faced, the price of the branded EpiPen hasn't changed, Duhigg noted on a recent trip to the pharmacy, though the company did introduce a generic that has a list price of $ 300.

Not only does the company provide prescription drug plans to businesses nationwide, but it does so on a transparent fee basis — every client knows exactly where his or her money goes.

Currently, they pay less than developed countries for drugs, so companies don't make as much money there.

CreditCards.com (2013) reported, «nearly all banks and credit card companies, reluctant to run afoul of federal drug and banking laws that remain on the books, refuse to do business with even state - licensed sellers of marijuana.

Insurers have been striking deals with pharma companies that will land them discounts on pricey drugs if those treatments don't demonstrably improve patients» health outcomes; hospitals are penalized if they have high rates of patient readmissions.

And Valeant's round - about method of funding research, if that's what it's actually doing, seems a lot less cost effective, with all of the bankers and lawyers and hedge fund managers taking chunks of deals than if drug companies directly devoted a portion of their sales toward finding new drugs.

By bringing a drug that's been well - established as safe in other markets to the U.S. for the first time in order to treat a rare disease, the company doesn't just control its pricing destiny — it will also receive a coveted «priority review voucher» which it can hawk to another firm for tens (or even hundreds) of millions of dollars.

While Tesaro is remaining publicly coy for now, a buyout has always been in the cards as big pharma companies continue to snap up biotechs that have already done drug development legwork for them.

The idea is that the deal could help insulate the companies in case Amazon does make an ambitious move into selling drugs, as well as give the combined improved leverage in negotiations with drug companies.

«Criminals use U.S. shell companies to commit financial fraud, drug trafficking, even terrorist financing, in part because our states don't require anyone to name the owners of the companies they form,» Levin said in an email to Reuters.

Saunders said in an interview that the five options considered in the drug company's review are deploying capital to buy back shares, doing divestitures, splitting the company, making acquisitions, or continuing to operate Allergan as is.

Allergan Plc's chief executive on Monday said he was opposed to fundamental changes to the drug company's business strategy, even as its board considers drastic moves like splitting the company, selling off assets or doing deals to turn around a steep drop in its share price.

«The intensifying battle for negotiating power and market share will lead companies to do acquisitions across traditional industry boundary lines,» said Erik Gordon, a professor at the Ross School of Business at the University of Michigan who studies the drug industry.

The talks between CVS and Aetna appear to be in part an attempt to fend off a move by Amazon into the drug - selling business — or at least to insulate the companies in case Amazon does invade.

«You don't like companies doing drug research and market based pricing?

The suit contended that the companies did so by inflating the published average wholesale price of the drug, giving free samples to doctors knowing they would charge patients and insurers for them, and giving incentives to doctors so that they would prescribe Lupron instead of less costly alternatives.

Bayer said in a statement that it doesn't control the cost for patients at the pharmacy, because copays are determined by insurers and pharmacy - benefit managers — an argument that pharmaceuticals companies have long made when facing criticism over drug prices.

One of the great findings of this study is that you can be in a great company and be doing it in steel, in drug stores, or in grocery stores.

2:53 pm ET: Cramer just said that Facebook needs to do a better job of proactively hunting for bad content on Facebook, specifically that the company needs to take down «illegal drug sites» on the service.

In addition, the company did a good job protecting its top - selling drug, Remicade, from biosimilar competition while also enjoying strong sales growth for products like Darzalex and Stelara.

«This was literally a drug company that was doing no [research and development].

By August, the company, which sells thousands of drugs and says it fills one in every 13 American prescriptions, was making mea culpas and renewing its promise to «do what's right, not what's easy,» as the company's mission statement goes.

But she doesn't expect Trump to propose any actions that would keep the companies from setting higher prices for drugs.

First, patents are often taken out to use as legal weapons by huge companies to fight off their competitors even if they do not plan on completing trials for the drug.

However, seeing a high number shouldn't be all that surprising, especially since almost half of the companies the biotech fund holds don't even have a drug on the market yet, so profits could be a long ways away — and this is just the nature of the industry.

Biotech companies that don't have new drugs or therapies in the pipeline yet (about 40 percent of all those that went public last year, in fact) tend to take advantage of an IPO window because they have serious cost burdens --- like multiple drug tests and regulatory approval --- that other VC - backed companies don't have.